维普中文期刊产品整合服务
27篇 您的检索式:作者名="Jong AD"
    题名 作者 年代 出处 被引量
1Comparative susceptibilities of various animal pathogenic mycoplasrnas to fluoroquinolones 显示文摘Hannan PCT Windsor CD Jong AD 1997Antimicrob Agents Chemother1997,41,9:1
2H5N1 influenza in Hong Kong: virus characterizations 显示文摘Osterhaus AD de Jong JC Rimmelzwaan GF 2002Vaccine2002,20,2:1
3Psychological safety and social support in groupware adoption: A multi-level assessment in education显示文摘Jeroen Schepers Ad de Jong Martin Wetzels Ko de Ruyter 2007Computers & Education2007,,2:1
4Hypertension and renal disease:role of microalbuminuria 显示文摘Janssen AD De Jong PE De Zeeuw D 1966J Hypertens Suppl1966,14,5:1
5Horizontal and vertical communication as determinants of professional and organisational identification显示文摘Jos Bartels Oscar Peters Menno de Jong Ad Pruyn Marjolijn van der Molen 2010Personnel Review2010,,2:1
6A pandemic waming显示文摘Jong JC Class EC Osternaus AD 1997Nature1997,389,:1
7Antecedents and Consequences of Group Potency : A Study of Self-Managing ServiceTeams显示文摘de Jong Ad Ko de Ruyter Martin W 2005Management Science2005,,11:1
8High exposures to bioactivated eyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy 显示文摘de Jonge ME Huitema AD Beijnen JH 2006Br J Cancer2006,94,9:1
9A pandemic warning显示文摘de Jong JC Class EC Ostemaus AD 0,,6651:1
10Results of a study on fatigue in breast cancer patients receiving adjuvant chemotherapy:the first four days after treatment are the worst显示文摘de Jong N Kester AD Schouten HC 2007Pflege Z2007,60,11:1
11Course of fatigue between two cycles of adjuvant chemotherapy in breast cancer patients 显示文摘de Jong N Kester AD Schouten HC 2006Cancer Nurs2006,29,6:1
12Aprepitant inhibits cyclophosphamide bioactivation and thiotepa metabolism 显示文摘de Jonge ME Huitema AD Hohkamp M J 2005Cancer Chemother Pharmacol2005,56,4:1
13Hypertension and renal disease:role of microalbuminuria显示文摘Janssen AD De Jong PE De Zeeuw D 1966J Hypertens Suppl1966,14,5:1
14Prevalence of-and risk factors for work disability in Dutch patients with inflammatory bowel disease显示文摘AIM To determine the prevalence of work disability in inflammatory bowel disease(IBD), and to assess risk factors associated with work disability.METHODS For this retrospective cohort study, we retrieved clinical data from the Dutch IBD Biobank on July 2014, containing electronic patient records of 3388 IBD patients treated in the eight University Medical Centers in the Netherlands. Prevalence of work disability was assessed in 2794 IBD patients and compared with the general Dutch population. Multivariate analyses were performed for work disability(sick leave, partial and full disability) and long-term full work disability(> 80% work disability for > 2 years).RESULTS Prevalence of work disability was higher in Crohn's disease(CD)(29%) and ulcerative colitis(UC)(19%) patients compared to the general Dutch population(7%). In all IBD patients, female sex, a lower education level, and extra-intestinal manifestations, were associated with work disability. In CD patients, an age > 40 years at diagnosis, disease duration > 15 years,smoking, surgical interventions, and anti-TNFα use were associated with work disability. In UC patients, an age > 55 years, and immunomodulator use were associated with work disability. In CD patients, a lower education level(OR = 1.62, 95%CI: 1.02-2.58), and in UC patients, disease complications(OR = 3.39, 95%CI: 1.09-10.58) were associated with long-term full work disability.CONCLUSION The prevalence of work disability in IBD patients is higher than in the general Dutch population. Early assessment of risk factors for work disability is necessary, as work disability is substantial among IBD patients.Lieke M Spekhorst Bas Oldenburg Ad A van Bodegraven Dirk J de Jong Floris Imhann Andrea E van der Meulen-de Jong Marieke J Pierik Janneke C van der Woude Gerard Dijkstra Geert D'Haens Mark Lowenberg Rinse K Weersma Eleonora AM Festen 2017World Journal of Gastroenterology2017,23,46:1
15Course of fatigue between two cycles of adjuvant chemotherapy in breast cancer patients显示文摘de Jong N Kester AD Schouten HC 2006Cancer Nursing2006,29,6:1
16High exposures to bio- activated cyclophosphamide aa-e related to the occurrence of veno-oc- clusive disease of the liver following high-dose chemotherapy显示文摘de Jonge ME Huitema AD Beijnen JH 2006Br J Cancer2006,94,9:1
17Relevance of colloid oncotic pressure regulation during neonatal and infant cardiopulmonary bypass: a prospective randomized study显示文摘Hanna D. Golab Thierry V. Scohy Peter L. de Jong Jenny Kissler Johanna J.M. Takkenberg Ad J.J.C. Bogers 2011European Journal of Cardio-Thoracic Surgery2011,,6:1
18Clinical pharmacokinetics of cyclophosphamide显示文摘De Jonge ME Huitema AD Rodenhuis S 2005Clin Pharmacokinet2005,44,11:1
19High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy显示文摘de Jonge ME Huitema AD Beijnen JH 2006Br J Cancer2006,94,9:1
20Long-term follow-up after repair of Ebstein’s anomaly显示文摘Meindert Palmen Peter L. de Jong Loes M.A. Klieverik Angelique C. Venema Folkert J. Meijboom Ad J.J.C. Bogers 2008European Journal of Cardio-Thoracic Surgery2008,,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费